Cervi; Giovanni

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cervi; Giovanni.The latest application filed is for "pyrazolyl-pyrimidine derivatives as kinase inhibitors".

Company Profile

0.17.14

Cervi; Giovanni - Como N/A IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrazolyl-pyrimidine derivatives as kinase inhibitors Grant 9,284,298 - Casuscelli , et al. March 15, 2	2016-03-15
Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors Grant 8,993,594 - Papeo , et al. March 31, 2	2015-03-31
Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity Grant 8,981,092 - Mirizzi , et al. March 17, 2	2015-03-17
3,4-diarylpyrazoles as protein kinase inhibitors Grant 8,946,250 - Pulici , et al. February 3, 2	2015-02-03
Pyrazolyl-pyrimidine Derivatives As Kinase Inhibitors App 20140051708 - Casuscelli; Francesco ; et al.	2014-02-20
Isoquinolin-1(2h)-one Derivatives As Parp-1 Inhibitors App 20140045846 - Papeo; Gianluca Mariano Enrico ; et al.	2014-02-13
3,4-diarylpyrazoles As Protein Kinase Inhibitors App 20140005150 - Pulici; Maurizio ; et al.	2014-01-02
Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors Grant 8,592,416 - Papeo , et al. November 26, 2	2013-11-26
3,4-diarylpyrazoles as protein kinase inhibitors Grant 8,541,575 - Pulici , et al. September 24, 2	2013-09-24
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them Grant 8,513,241 - Cervi , et al. August 20, 2	2013-08-20
3,4-dihydro-2h-pyrrolo[1,2-a]pyrazin-1-one Derivatives For The Modulation Of The Activity Of Protein Kinases App 20130137696 - Mirizzi; Danilo ; et al.	2013-05-30
3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases Grant 8,394,802 - Mirizzi , et al. March 12, 2	2013-03-12
3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Derivatives Active As Kinase Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Comprising Them App 20120232085 - CERVI; Giovanni ; et al.	2012-09-13
3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them Grant 8,207,165 - Cervi , et al. June 26, 2	2012-06-26
Isoquinolin-1 (2h) -one Derivatives As Parp-1 Inhibitors App 20120157454 - Papeo; Gianluca Mariano Enrico ; et al.	2012-06-21
3,4-DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES App 20110251179 - Mirizzi; Danilo ; et al.	2011-10-13
3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one Derivatives Active As Kinase Inhibitors, Process For Their Preparation And Pharmaceutical Compositions Comprising Them App 20110183971 - Cervi; Giovanni ; et al.	2011-07-28
3,4-diarylpyrazoles As Protein Kinase Inhibitors App 20110144068 - Pulici; Maurizio ; et al.	2011-06-16
Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them App 20060264493 - Vanotti; Ermes ; et al.	2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.